4D Molecular Therapeutics (FDMT) Revenue (2020 - 2026)
4D Molecular Therapeutics (FDMT) reported Revenue of $3.0 million for Q1 2026, up 21664.29% year-over-year from N/an in Q1 2025, and down 96.42% quarter-over-quarter from $85.1 million in Q4 2025.
4D Molecular Therapeutics (FDMT) Revenue (2020 - 2026) Analysis & Trends
4D Molecular Therapeutics (FDMT) has 7 years of Revenue data on file, last reported at $3.0 million in Q1 2026.
- Revenue for Q1 2026 came in at $3.0 million, up 21664.29% year-over-year; the trailing twelve-month figure through Mar 2026 was $88.2 million (up 383560.87% YoY), and the FY2025 annual result was $85.2 million, up 230194.59% from the prior year.
- Revenue eased to $3.0 million in Q1 2026 per FDMT's latest filing, from $85.1 million in the prior quarter.
- Over five years, Revenue peaked at $85.1 million in Q4 2025 and troughed at -$19000.0 in Q4 2023.
- A 5-year average of $6.6 million and a median of $162000.0 in 2022 frame the typical range for Revenue.
- The sharpest annual moves came in 2023 and 2025: Revenue tumbled 101.52% in 2023, then jumped 8508900.0% in 2025.
- A 5-year view of Revenue shows it stood at $1.2 million in 2022, then sank by 101.52% to -$19000.0 in 2023, then soared by 105.26% to $1000.0 in 2024, then jumped by 8508900.0% to $85.1 million in 2025, then plunged by 96.42% to $3.0 million in 2026.
- Business Quant data shows FDMT's Revenue at $3.0 million in Q1 2026, $85.1 million in Q4 2025, and $90000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 5.21 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 306.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 2.99 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | 4D Molecular Therapeutics | 656.48 Mn | 656.48 Mn | - | 3.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.05 Mn |
| Dec 31, 2025 | 85.09 Mn |
| Sep 30, 2025 | 90,000.00 |
| Jun 30, 2025 | 15,000.00 |
| Mar 31, 2025 | 14,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Sep 30, 2024 | 3,000.00 |
| Jun 30, 2024 | 5,000.00 |
| Mar 31, 2024 | 28,000.00 |
| Dec 31, 2023 | -19,000.00 |
| Sep 30, 2023 | 20.20 Mn |
| Jun 30, 2023 | 239,000.00 |
| Mar 31, 2023 | 298,000.00 |
| Dec 31, 2022 | 1.25 Mn |
| Sep 30, 2022 | 500,000.00 |
| Jun 30, 2022 | 162,000.00 |
| Mar 31, 2022 | 1.22 Mn |
| Dec 31, 2021 | 92,000.00 |
| Sep 30, 2021 | 1.37 Mn |
| Jun 30, 2021 | 14.58 Mn |